Browsing by Author "Cerda Rojas, Ariel Patricio"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    A simple RNA preparation method for SARS-CoV-2 detection by RT-qPCR
    (2020) Wozniak Banchero, Aniela; Cerda Rojas, Ariel Patricio; Lamig Giannini, Liliana Andrea; Solari Gajardo, Sandra; Guzmán Durán, Ana María; Riveras Hernández, Eleodoro Javier; Ferres Garrido, Marcela Viviana; Gutiérrez Ilabaca, Rodrigo Antonio; García Cañete, Patricia; Ibarra Henriquez, C.; Sebastian, V.; Armijo, G.; Lamig, L.; Miranda, C.; Lagos, M.; Quiroga, T.; Hitschfeld, S.
  • No Thumbnail Available
    Item
    An Open One-Step RT-qPCR for SARS-CoV-2 detection
    (Public Library Science, 2024) Cerda Rojas, Ariel Patricio; Rivera, Maira; Armijo, Grace; Ibarra-Henríquez, Catalina; Reyes, Javiera; Blázquez Sánchez, Paula; Avilés, Javiera; Arce, Anibal; Seguel, Aldo; Brown, Alexander J.; Vásquez, Yesseny; Cortez-San Martín, Marcelo; Cubillos, Francisco A.; García, Patricia; Ferrés, Marcela; Ramírez Sarmiento, César Antonio; Federici, Fernan; Gutiérrez, Rodrigo A.
    The COVID-19 pandemic has resulted in millions of deaths globally, and while several diagnostic systems were proposed, real-time reverse transcription polymerase chain reaction (RT-PCR) remains the gold standard. However, diagnostic reagents, including enzymes used in RT-PCR, are subject to centralized production models and intellectual property restrictions, which present a challenge for less developed countries. With the aim of generating a standardized One-Step open RT-qPCR protocol to detect SARS-CoV-2 RNA in clinical samples, we purified and tested recombinant enzymes and a non-proprietary buffer. The protocol utilized M-MLV RT and Taq DNA pol enzymes to perform a Taqman probe-based assay. Synthetic RNA samples were used to validate the One-Step RT-qPCR components, demonstrating sensitivity comparable to a commercial kit routinely employed in clinical settings for patient diagnosis. Further evaluation on 40 clinical samples (20 positive and 20 negative) confirmed its comparable diagnostic accuracy. This study represents a proof of concept for an open approach to developing diagnostic kits for viral infections and diseases, which could provide a cost-effective and accessible solution for less developed countries.